Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-583-1 | CAS number: 108-44-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- - modified LLNA(IMDS): Measurement of cell counts instead of radioactive labelling. In addition, measurements of ear swelling and ear weights were done to discriminate the irritating potential from the sensitizing potential of the test substance
- Principles of method if other than guideline:
- Modified LLNA (IMDS; Integrated Model for the Differentiation of Skin Reactions).
Modifications are authorized in the OECD TG 429 and in the Note of Guidance SWP/2145/00 of the CPMP (2001).
Information on validation of IMDS and scientific justification is given in : Vohr HW et al, Arch Toxicol 73, 501-509 (2000) and Ehling G et al, Toxicology 212, 60-68 and 69-79 (2005). - GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- m-toluidine
- EC Number:
- 203-583-1
- EC Name:
- m-toluidine
- Cas Number:
- 108-44-1
- Molecular formula:
- C7H9N
- IUPAC Name:
- 3-methylaniline
- Test material form:
- other: liquid
- Details on test material:
- purity. 99.7 %
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 9
- Weight at study initiation: 26-31 g
- Housing: individual
- Diet ad libitum
- Water ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 40 - 70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Remarks:
- the stability of thetest item was analytically verified for up to 2 hours
- Concentration:
- 0, 2, 10, 50 %
- No. of animals per dose:
- 6
- Details on study design:
- TREATMENT PREPARATION AND ADMINISTRATION
The test item in the formulation and the vehicle were applied epicutaneously onto the dorsal part of both ears of the animals . This treatment was repeated on 3 consecutive days. the volume administered was 25 µl/ear. The used concentrations were based on the experiences with this test system and the properties of the test item.
The animals were anaestetized by inhalation of carbon dioxide and sacrificed one day after the last application. The approprialte organs were then removed. Lymphatic organs (auricular lymphnodes were transferred into physiological saline (PBS).
Investigations:
-weight of lymph nodes
-cell counts in lymph nodes
-stimulation index is calculated by
dividing the absolute number of weight or cell counts of the substance treated lymph nodesby vehicle treated ones
-ear swelling
-ear weight
-body weights - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- When it was statistically reasonable , the values from treated groups were compared with those from the control group by a one-wayanalysis of variance (ANOVA) when the variances are considered homogeneous according to a homogenicity testing like Cochran's test. Alternatively in the variances aer considered to be heterogenous (p<=0.05) a non-parametric Kruskal-Wallis test has been used. (Kruskal-Wallis ANOVA) at significance level of 5 %. Two sided multiple test procedure were done according to Dunnett or Bonferroni-Holm, respectively. Outlying values in the LN weights were eliminated at a probability level of 99 % by Nalimov's method. In addition, for the LLNA/IMDS the smalest significant differences in the meatns were calculated by Scheffel's method, which according to Sachs can be used tof both equal and unequal sizes.
Results and discussion
- Positive control results:
- Alpha hexyl cinnamic aldehyd, checked in regular intervals, shows a clear sensitizing potential in the local lymph node assay (IMDS)
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- The NMRI mice did not show an increase in the stimulation indices for cell counts or for weights of the draining lymph nodes after application of the test item m-toluidin. The "positive level" which is 1.4 for the cell count index, was never reached or exceeded in any dose group (0.92, 0.98, 1.16). The "positive level" of ear swelling which is 2x10-2 mm increase, has not been reached or exceeded in any dose group.: The body weights of the animals were not affected by any treatment.
- Parameter:
- SI
- Remarks:
- Cell count index
- Value:
- 1
- Test group / Remarks:
- Dose = 0% - 6 control animals
- Remarks on result:
- other: Modified LLNA: measurement of cell counts instead of radioactive labelling
- Parameter:
- SI
- Remarks:
- Cell count index
- Value:
- 0.92
- Test group / Remarks:
- Dose = 2% - 6 animals per test group
- Remarks on result:
- other: Modified LLNA: measurement of cell counts instead of radioactive labelling
- Parameter:
- SI
- Remarks:
- Cell count index
- Value:
- 0.98
- Test group / Remarks:
- Dose = 10% - 6 animals per test group
- Remarks on result:
- other: Modified LLNA: measurement of cell counts instead of radioactive labelling
- Parameter:
- SI
- Remarks:
- Cell count index
- Value:
- 1.16
- Test group / Remarks:
- Dose = 50% - 6 animals per test group
- Remarks on result:
- other: Modified LLNA: measurement of cell counts instead of radioactive labelling
Any other information on results incl. tables
It has to be clarified that the "positive level" mentioned above are exclusively defined for the NMRI outbred mice used in the study. Such positive limits have to be calculated for each strain of mice individually.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Executive summary:
A LLNA/IMDS was carried out in female NMRI mice after epicutaneous application of a formulation containing 2, 10 or 50 % of the test item o-toluidin for 3 consecutive days onto both ears of the animals. In conclusion, the results show that the test item m-toluidin has no sensitizing potential in mice after dermal application of up to and including a 50 % concentration. In addition, no indication for a non-specific (irritant) activation was detected. Therefore, the concentration of 50 % turned out to be the NOEL for the parameters investigated in this study with respect to skin sensitization (Vohr 2009).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
